Nicox Provides First Quarter 2021 Business Update and Financial Highlights
NCX 470 Phase 3 trials in glaucoma on track for top-line results in Q2 2022 (Mont Blanc) and Q4 2022 (Denali) NCX 4251 Mississippi Phase 2b trial in blepharitis on track for top-line results in Q4 2021 U.S. prescriptions for VYZULTA® in Q1 2021 increased …